Literature DB >> 32238612

Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.

Namita Ravikumar1, Karthi Nallasamy1, Arun Bansal2, Suresh Kumar Angurana1, G V Basavaraja3, Manu Sundaram4, Rakesh Lodha5, Dhiren Gupta6, Muralidharan Jayashree1.   

Abstract

First reported in China, the 2019 novel coronavirus has been spreading across the globe. Till 26 March, 2020, 416,686 cases have been diagnosed and 18,589 have died the world over. The coronavirus disease mainly starts with a respiratory illness and about 5-16% require intensive care management for acute respiratory distress syndrome (ARDS) and multi-organ dysfunction. Children account for about 1-2% of the total cases, and 6% of these fall under severe or critical category requiring pediatric intensive care unit (PICU) care. Diagnosis involves a combination of clinical and epidemiological features with laboratory confirmation. Preparedness strategies for managing this pandemic are the need of the hour, and involve setting up cohort ICUs with isolation rooms. Re-allocation of resources in managing this crisis involves careful planning, halting elective surgeries and training of healthcare workers. Strict adherence to infection control like personal protective equipment and disinfection is the key to contain the disease transmission. Although many therapies have been tried in various regions, there is a lack of strong evidence to recommend anti-virals or immunomodulatory drugs.

Entities:  

Mesh:

Year:  2020        PMID: 32238612      PMCID: PMC7182738     

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  32 in total

1.  Care for Critically Ill Patients With COVID-19.

Authors:  Srinivas Murthy; Charles D Gomersall; Robert A Fowler
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

2.  [Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen].

Authors:  X F Wang; J Yuan; Y J Zheng; J Chen; Y M Bao; Y R Wang; L F Wang; H Li; J X Zeng; Y H Zhang; Y X Liu; L Liu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2020-02-17

3.  Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

Authors:  K S Chan; S T Lai; C M Chu; E Tsui; C Y Tam; M M L Wong; M W Tse; T L Que; J S M Peiris; J Sung; V C W Wong; K Y Yuen
Journal:  Hong Kong Med J       Date:  2003-12       Impact factor: 2.227

4.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.

Authors:  Martin J Vincent; Eric Bergeron; Suzanne Benjannet; Bobbie R Erickson; Pierre E Rollin; Thomas G Ksiazek; Nabil G Seidah; Stuart T Nichol
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

5.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

6.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

7.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

8.  Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.

Authors:  Hongde Hu; Fenglian Ma; Xin Wei; Yuan Fang
Journal:  Eur Heart J       Date:  2021-01-07       Impact factor: 29.983

9.  Convalescent plasma as a potential therapy for COVID-19.

Authors:  Long Chen; Jing Xiong; Lei Bao; Yuan Shi
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071

Review 10.  Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.

Authors:  Kunling Shen; Yonghong Yang; Tianyou Wang; Dongchi Zhao; Yi Jiang; Runming Jin; Yuejie Zheng; Baoping Xu; Zhengde Xie; Likai Lin; Yunxiao Shang; Xiaoxia Lu; Sainan Shu; Yan Bai; Jikui Deng; Min Lu; Leping Ye; Xuefeng Wang; Yongyan Wang; Liwei Gao
Journal:  World J Pediatr       Date:  2020-02-07       Impact factor: 9.186

View more
  4 in total

1.  Simulathon 2020: Integrating Simulation Period Prevalence Methodology Into the COVID-19 Disaster Management Cycle in India.

Authors:  Sujatha Thyagarajan; Geethanjali Ramachandra; Vijayanand Jamalpuri; Aaron W Calhoun; Vinay Nadkarni; Ellen S Deutsch
Journal:  Simul Healthc       Date:  2021-08-16       Impact factor: 2.690

2.  Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.

Authors:  Manu Sundaram; Namita Ravikumar; Arun Bansal; Karthi Nallasamy; G V Basavaraja; Rakesh Lodha; Dhiren Gupta; Marti Pons Odena; R N Ram Ashwath; Muralidharan Jayashree
Journal:  Indian Pediatr       Date:  2020-03-29       Impact factor: 1.411

Review 3.  COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.

Authors:  Sukrita Bhattacharjee; Mainak Banerjee; Rimesh Pal
Journal:  Indian Pediatr       Date:  2020-06-24       Impact factor: 1.411

4.  Using Social Media for Rapid Information Dissemination in a Pandemic: #PedsICU and Coronavirus Disease 2019.

Authors:  Sapna R Kudchadkar; Christopher L Carroll
Journal:  Pediatr Crit Care Med       Date:  2020-08       Impact factor: 3.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.